BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 5:16:00 PM | Browse: 990 | Download: 911
 |
Received |
|
2013-11-02 10:17 |
 |
Peer-Review Started |
|
2013-11-02 19:33 |
 |
To Make the First Decision |
|
2013-12-16 18:03 |
 |
Return for Revision |
|
2013-12-17 13:54 |
 |
Revised |
|
2014-01-07 14:06 |
 |
Second Decision |
|
2014-01-20 18:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-20 19:18 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-03-01 10:45 |
 |
Typeset the Manuscript |
|
2014-05-02 21:47 |
 |
Publish the Manuscript Online |
|
2014-05-28 11:45 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Meta-Analysis |
Article Title |
Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jia Li, Jian-Zhi Gao, Jing-Li Du and Li-Xin Wei |
Funding Agency and Grant Number |
|
Corresponding Author |
Li-Xin Wei, PhD, Department of Pathology, Chinese PLA General Hospital, Haidian District, 28 Fuxing Road, Beijing 100853, China. weilx301@263.net |
Key Words |
Hepatocellular carcinoma; Glypican-3; Prognosis; Clinicopathological parameter; Meta-analysis |
Core Tip |
Glypican-3 (GPC3) is known to be a specific and available molecular marker for the diagnosis of hepatocellular carcinoma (HCC). However, the prognostic value of GPC3 overexpression in patients with HCC is less researched and remains controversial. We performed the meta-analysis including six eligible studies and demonstrated that GPC3 overexpression was associated with poor overall survival and disease-free survival in HCC. We also found that GPC3 expression was closely related with tumor vascular invasion, hepatic cirrhosis, tumor grade and tumor stage in HCC. |
Publish Date |
2014-05-28 11:45 |
Citation |
Li J, Gao JZ, Du JL, Wei LX. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(20): 6336-6344 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i20/6336.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i20.6336 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345